Money and Me: How the expensive US stock market is being impacted by trends in AI

Money and Me: How the expensive US stock market is being impacted by trends in AI

Founder of the Tao of Trading, Simon Ree, joins Michelle Martin to discuss the market’s current valuation landscape.

He highlights that the Cyclically-Adjusted PE (CAPE) ratio stands at 38 - making U.S. stocks 97% more expensive than historical averages.

Against this backdrop, how should investors assess their exposure to AI stocks as concerns grow over AI infrastructure spending?

Is AI optimism strong enough to offset uncertainty surrounding Trump’s tariffs?

This episode unpacks Nvidia’s $600 billion market wipeout, the risks to AI investments, and whether investors should rethink their AI strategies.

Plus, insights on Trump’s tariffs, their impact on inflation, and potential shifts in global supply chains.

See omnystudio.com/listener for privacy information.

Episoder(3750)

Money and Me: If a pipe in the common area of your condo leaks and damages your home, who is responsible?

Money and Me: If a pipe in the common area of your condo leaks and damages your home, who is responsible?

It's been a wet New Year so today we focus on water damage and your money. When a roof in a common area of a condominium leaks, who is responsible for the rectification costs?  What do the acronyms MC...

2 Jan 202419min

Money and Me: How should you invest in 2024?

Money and Me: How should you invest in 2024?

Surprises - that's how many might describe the whirlwind of the year that we've had. That said, how did global markets perform in 2023? What lessons can be drawn from this year that we could use to he...

29 Des 202325min

Market View: Wall Street 2023 forecast goes wrong, US Markets Santa Claus rally, Nvidia, X, S-REITs and Tourism related stocks, Japan's economy, Xiaomi entry into EV space, China's 2024 economy forecast

Market View: Wall Street 2023 forecast goes wrong, US Markets Santa Claus rally, Nvidia, X, S-REITs and Tourism related stocks, Japan's economy, Xiaomi entry into EV space, China's 2024 economy forecast

Why was the consensus by Wall Street strategists so wrong in 2023? What does the recent 'Santa Claus' rally indicate about what's to come in 2024? And does Xiaomi have what it takes to take on the lik...

29 Des 202317min

Money and Me: To what extent will China’s crackdown on gaming hurt its big tech stocks?

Money and Me: To what extent will China’s crackdown on gaming hurt its big tech stocks?

What critical economic challenges will China face in 2024 that investors should be thinking through? As the year comes to an end, how can investors think through how their portfolios have performed? L...

28 Des 202324min

Market View: BYD overtakes Tesla, Softbank, Microsoft & OpenAI, Amazon Prime, Apple, Cytokinetics, ComfortDelGro, Reasons for a bullish S&P 500 in 2024, Tencent & NetEase reaction to new online gaming rules

Market View: BYD overtakes Tesla, Softbank, Microsoft & OpenAI, Amazon Prime, Apple, Cytokinetics, ComfortDelGro, Reasons for a bullish S&P 500 in 2024, Tencent & NetEase reaction to new online gaming rules

What’s driving BYD’s success to overtake Tesla as the world’s most popular EV maker? What are some reasons stock investors will see a bullish 2024 for the S&P 500? And how have Chinese gaming stocks r...

28 Des 202322min

Money and Me: $250 million in gains over 5 years with Singapore property

Money and Me: $250 million in gains over 5 years with Singapore property

Michelle Martin finds out what information I Quadrant - a  Property investing community -members have access to. She also learns how the power of community is being harnessed for real property deals w...

27 Des 202322min

Market View: Bristol Myers $4.1 billion acquisition, Microstrategy, Intel, Adani Green, Apple, Vibecession ending, Chinese gaming firms share buybacks, Goldman’s 2023 lesson on China, Astrazeneca buys Cancer Drug Developer for $1.2 billion

Market View: Bristol Myers $4.1 billion acquisition, Microstrategy, Intel, Adani Green, Apple, Vibecession ending, Chinese gaming firms share buybacks, Goldman’s 2023 lesson on China, Astrazeneca buys Cancer Drug Developer for $1.2 billion

Is the ‘vibecession’ really coming to an end? What’s the latest on Pharmaceutical acquisitions? And why are Chinese gaming firms unveiling share buybacks even after the latest regulatory move unnerved...

27 Des 202320min

Money and Me: What first-time property buyers are doing

Money and Me: What first-time property buyers are doing

What do first time property buyers need to be aware of in today’s market. Are there different strategies being used. Michelle Martin finds out with Mister Boon, Senior Group Division Director, ERA Rea...

26 Des 202323min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
utbytte
pengepodden-2
pengesnakk
livet-pa-veien-med-jan-erik-larssen
rss-sunn-okonomi
morgenkaffen-med-finansavisen
tid-er-penger-en-podcast-med-peter-warren
okonomiamatorene
finansredaksjonen
lederpodden
liberal-halvtime
rss-markedspuls-2
rss-impressions-2
rss-andelige-tanker-med-camillo